5α-reductase inhibitors impact prognosis of urothelial carcinoma.

Chien-Sheng WangChing-Chia LiYung-Shun JuanWen-Jeng WuHsiang Ying Lee

Published in: BMC cancer (2020)

Patients who receive 5-ARIs have lower bladder cancer related mortality compared to those who don't. 5-ARIs may prove to be a viable strategy to improve bladder cancer outcomes.

Keyphrases

spinal cord injury
cardiovascular events
risk factors
cardiovascular disease
adipose tissue
glycemic control